
    
      Randomized clinical trial with 3 arms : hydroxychloroquine group, 300 subjects/azithromycin
      group, 300 subjects/ placebo of hydroxychloroquine group, 300 subjects. Hospital workers
      workers will be invited to participate in the study in each hospital and they will be
      included after giving their consent, assessment of their eligibility criteria, endonasal PCR
      and serolology at baseline. They will be randomized in one of the 3 arms, receive their
      treatment and will be followed by physical visit (at Day 2, Day 5, Day 15, Day 28) and by
      phone (at Day) 40 days with clinical data collection (tolerance and clinical signs of
      infection). At the end of treatment, another serology will be collected.
    
  